Children's National Hospital Site Consortium - Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) Operations and Collaborations Center (UM2 Clinical Trial Optional)

国家儿童医院基地联盟 - HIV/艾滋病干预青少年医学试验网络 (ATN) 运营和合作中心(UM2 临床试验可选)

基本信息

  • 批准号:
    10599559
  • 负责人:
  • 金额:
    $ 33.5万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-09-22 至 2029-06-30
  • 项目状态:
    未结题

项目摘要

ABSTRACT Children's National Hospital (CNH) CRS Despite the substantial progress in the HIV epidemic, adolescents, and young adults (AYA) aged 13-24 years living with HIV have worse health outcomes compared to any other age groups in the United States (US). Children's National Hospital (CNH), provides comprehensive HIV prevention and treatment services to the majority of AYA from the District of Columbia (DC) eligible metropolitan area (EMA) including three national HIV epidemic hotspots—Washington, DC, and two Maryland counties (Montgomery and Prince George's). Within DC, which continues to have the highest rates of new HIV infection in the United States, AYA have a high HIV prevalence of 0.3%, and high incidence of sexually transmitted infections, placing them at substantial risk for acquiring HIV. Through universal HIV counselling and opt-out screening, CNH reaches out to thousands of AYA in the DC EMA yearly with HIV prevention and testing services. Currently ~300 primarily minority Black AYA are in care at CNH for pre-exposure prophylaxis and antiretroviral treatment. CNH has a longstanding history of collaboration within local, regional, and national scientific networks, including prior participation in the Adolescent Trials Network (ATN). CNH has served as a successful recruitment site to multiple industry-sponsored investigational new drug clinical trials and received an uninterrupted line of DC Department of Health funding for HIV prevention and testing for more than 10 years. CNH has well-established partnerships with local and regional community-based organizations and a strong track-record of leadership in AYA HIV research within the broader local community of academic and community-based investigators, including its active role in DC Center for AIDS Research and DC Cohort Study. The overarching goal of the proposed ATN CNH consortium site is to contribute to the Westat-led ATN Operation and Collaboration Center (OCC) long-term scientific impact while expanding its role in delivering direct public health impacts on the local, regional, and national HIV epidemic among AYA. To achieve this goal, CNH will: (a) actively participate in the development and implementation of the Westat-led ATN OCC clinical trials identified by the ATN Executive and Scientific Leadership Committees; (b) deliver innovative solutions to optimize recruitment, enrollment, and retention of AYA at multiple sites in the DC EMA in ATN studies and ensure local laboratory capacity and pharmacy support; (c) propose novel concepts, approaches, and methodologies in implementation and clinical science, and development and optimization of biomedical prevention and treatment tools for AYA; and (d) meaningfully contribute to the Westat-led ATN OCC leadership model through sustained CNH site and AYA community engagement, expanding network collaborations through established regional collaborations among clinical, academic, community-based AYA focused partners, local DOHs, and schools. By participating in the Westat-led ATN OCC, CNH is uniquely positioned to contribute to advancing the National HIV/AIDS Strategy and the national plan of Ending the HIV Epidemic in the United States.
摘要国立儿童医院(CNH)CRS 尽管在艾滋病毒流行方面取得了实质性进展,但13-24岁的青少年和年轻人(AYA) 与美国其他年龄组相比,艾滋病毒感染者的健康状况更差。 国家儿童医院(CNH)为儿童提供全面的艾滋病毒预防和治疗服务。 来自哥伦比亚特区(DC)的大多数AYA符合大都市区(EMA)的条件,包括三个国家 艾滋病流行的热点--华盛顿特区和两个马里兰州县(蒙哥马利和乔治王子)。 在华盛顿特区,艾滋病毒新感染率仍然是美国最高的,AYA的感染率是美国最高的。 艾滋病毒感染率高达0.3%,性传播感染发生率很高,使其处于相当高的水平 感染艾滋病毒的风险。通过普遍的艾滋病毒咨询和选择退出筛查,CNH接触到 每年在DC EMA为数千名AYA提供艾滋病毒预防和检测服务。目前,主要有300 少数黑人阿雅人在CNH接受接触前预防和抗逆转录病毒治疗。CNH有一个 在地方、区域和国家科学网络内的长期合作历史,包括以前的 青少年试验网络(ATN)。CNH已经成为一个成功的招聘网站, 多个行业赞助的研究性新药临床试验,并获得了不间断的DC 卫生署资助艾滋病毒预防和检测已超过10年。CNH已经建立了 与地方和区域社区组织建立伙伴关系,并在以下方面发挥领导作用 AYA艾滋病毒研究在更广泛的当地社区的学术和社区为基础的调查, 包括其在DC艾滋病研究中心和DC队列研究中的积极作用。的首要目标 拟议中的ATN CNH联合体网站将为Westat领导的ATN运营和协作中心做出贡献 (OCC)长期科学影响,同时扩大其在对当地公共卫生产生直接影响方面的作用, 艾滋病毒在AYA中的区域和国家流行。为实现这一目标,CNH将:(a)积极参与 开发和实施由ATN执行官确定的Westat领导的ATN OCC临床试验 和科学领导委员会;(B)提供创新的解决方案,以优化招聘,招生, 在ATN研究中,在DC EMA的多个研究中心保留AYA,并确保当地实验室的能力, (c)提出新的概念,方法,以及实施和临床方法 科学、开发和优化AYA的生物医学预防和治疗工具;以及 (d)通过持续的CNH网站和AYA,为Westat领导的ATN OCC领导模式做出有意义的贡献 社区参与,通过建立区域合作扩大网络合作, 临床、学术、以社区为基础的AYA重点合作伙伴、当地卫生部和学校。通过参与 由Westat领导的ATN OCC,CNH在推进国家艾滋病毒/艾滋病战略方面具有独特的优势 以及结束美国艾滋病流行的国家计划。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Natella Yurievna Rakhmanina其他文献

Natella Yurievna Rakhmanina的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Natella Yurievna Rakhmanina', 18)}}的其他基金

Children's National Hospital Site Consortium - Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) Operations and Collaborations Center (UM2 Clinical Trial Optional)
国家儿童医院站点联盟 - HIV/艾滋病干预青少年医学试验网络 (ATN) 运营和合作中心(UM2 临床试验可选)
  • 批准号:
    10709605
  • 财政年份:
    2022
  • 资助金额:
    $ 33.5万
  • 项目类别:
Effect of Puberty on the Phamacokinetics of Efavirenz in HIV-infected Children
青春期对 HIV 感染儿童依非韦伦药代动力学的影响
  • 批准号:
    7687034
  • 财政年份:
    2009
  • 资助金额:
    $ 33.5万
  • 项目类别:
Effect of Puberty on the Phamacokinetics of Efavirenz in HIV-infected Children
青春期对 HIV 感染儿童依非韦伦药代动力学的影响
  • 批准号:
    8099653
  • 财政年份:
    2009
  • 资助金额:
    $ 33.5万
  • 项目类别:
Effect of Puberty on the Phamacokinetics of Efavirenz in HIV-infected Children
青春期对 HIV 感染儿童依非韦伦药代动力学的影响
  • 批准号:
    8306188
  • 财政年份:
    2009
  • 资助金额:
    $ 33.5万
  • 项目类别:
Effect of Puberty on the Phamacokinetics of Efavirenz in HIV-infected Children
青春期对 HIV 感染儿童依非韦伦药代动力学的影响
  • 批准号:
    7891190
  • 财政年份:
    2009
  • 资助金额:
    $ 33.5万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了